Perales, Miguel-Angel

Publications

Sort by

Co-Author Network

selected publications

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma. Blood cancer journal. 2020 Academic Article GET IT
Times cited: 151
Prognostic Factors for Postrelapse Survival after ex Vivo CD34⁺-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Geriatric syndromes in 2-year, progression-free survivors among older recipients of allogeneic hematopoietic cell transplantation. Bone marrow transplantation. 2020 Letter GET IT
Times cited: 4
DLBCL patients treated with CD19 CAR T cells experience a high burden of organ toxicities but low nonrelapse mortality. Blood advances. 2020 Academic Article GET IT
Times cited: 89
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood advances. 2020 Academic Article GET IT
Times cited: 18
Impact of Preemptive Therapy for Cytomegalovirus on Hospitalizations and Cost after Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Times cited: 16
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood. 2020 Academic Article GET IT
Times cited: 103
Engraftment kinetics after transplantation of double unit cord blood grafts combined with haplo-identical CD34+ cells without antithymocyte globulin. Leukemia. 2020 Academic Article GET IT
Times cited: 10
Response to Kawedia et al Letter to Editor in Response to the Article by McCune Et Al "Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement". Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Article GET IT
Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series. Bone marrow transplantation. 2020 Article GET IT
Impact of Preemptive Therapy for Cytomegalovirus on Toxicities after Allogeneic Hematopoietic Cell Transplantation in Clinical Practice: A Retrospective Single-Center Cohort Study. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Times cited: 38
CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overview. Bone marrow transplantation. 2020 Information Resource GET IT
Times cited: 5
Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Information Resource GET IT
Times cited: 58
Cytomegalovirus Viremia and Death After Hematopoietic Cell Transplantation: More Complex Than "To Have and Have Not"?. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2020 Article GET IT
Comparing CAR T-cell toxicity grading systems: application of the ASTCT grading system and implications for management. Blood advances. 2020 Academic Article GET IT
Times cited: 112
A Single-Center, Open-Label Trial of Isavuconazole Prophylaxis against Invasive Fungal Infection in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Times cited: 46
Acute Kidney Injury after CAR-T Cell Therapy: Low Incidence and Rapid Recovery. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2020 Academic Article GET IT
Times cited: 68
Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. The Journal of clinical investigation. 2020 Academic Article GET IT
Times cited: 176
Alternative donor transplantation for acute myeloid leukemia in patients aged ≥50 years: young HLA-matched unrelated or haploidentical donor?. Haematologica. 2020 Academic Article GET IT
Times cited: 25
Lack of a significant pharmacokinetic interaction between letermovir and calcineurin inhibitors in allogeneic HCT recipients. Bone marrow transplantation. 2020 Letter GET IT
Times cited: 2
Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin. Blood advances. 2020 Academic Article GET IT
Times cited: 35
Checkpoint inhibitors in AML: are we there yet?. British journal of haematology. 2019 Information Resource GET IT
Times cited: 7
Modern management of relapsed and refractory aggressive B-cell lymphoma: A perspective on the current treatment landscape and patient selection for CAR T-cell therapy. Blood reviews. 2019 Information Resource GET IT
Times cited: 14
Favorable long-term outcomes of hematopoietic stem cell transplantation for CMML with myeloablative conditioning, anti-thymocyte globulin, and CD34⁺ selected graft. Bone marrow transplantation. 2019 Letter GET IT
Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real-world experience. Transplant infectious disease : an official journal of the Transplantation Society. 2019 Academic Article GET IT
Times cited: 68
Ex Vivo T Cell-Depleted Hematopoietic Stem Cell Transplantation for Adult Patients with Acute Myelogenous Leukemia in First and Second Remission: Long-Term Disease-Free Survival with a Significantly Reduced Risk of Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 21
Presalvage International Staging System Stage and Other Important Outcome Associations in CD34⁺-Selected Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 9
Impact of geriatric vulnerabilities on allogeneic hematopoietic cell transplantation outcomes in older patients with hematologic malignancies. Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 39
Comparison of High Doses of Total Body Irradiation in Myeloablative Conditioning before Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 24
Hematopoietic Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Updated 2019 Evidence-Based Review from the American Society for Transplantation and Cellular Therapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Information Resource GET IT
Times cited: 29
Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Information Resource GET IT
Times cited: 43
CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma. Blood. 2019 Academic Article GET IT
Times cited: 59
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 12
Regarding "Recipients Receiving Better HLA-Matched Hematopoietic Cell Transplantation Grafts, Uncovered by a Novel HLA Typing Method, Have Superior Survival: A Retrospective Study". Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Letter GET IT
Times cited: 2
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 20
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)-an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT). Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 92
Standard Antithymocyte Globulin Dosing Results in Poorer Outcomes in Overexposed Patients after Ex Vivo CD34⁺ Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 15
Burden and impact of multifactorial geriatric syndromes in allogeneic hematopoietic cell transplantation for older adults. Blood advances. 2019 Academic Article GET IT
Times cited: 26
Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 8
Allogeneic haematopoietic cell transplantation impacts on outcomes of mantle cell lymphoma with TP53 alterations. British journal of haematology. 2018 Academic Article GET IT
Times cited: 52
CAR T cells: The future is already present. Medicina clinica. 2018 Academic Article GET IT
Times cited: 2
Expanding Therapeutic Opportunities for Hematopoietic Stem Cell Transplantation: T Cell Depletion as a Model for the Targeted Allograft. Annual review of medicine. 2018 Information Resource GET IT
Times cited: 4
Ex vivo and in vivo T cell-depleted allogeneic stem cell transplantation in patients with acute myeloid leukemia in first complete remission resulted in similar overall survival: on behalf of the ALWP of the EBMT and the MSKCC. Journal of hematology & oncology. 2018 Academic Article GET IT
Times cited: 16
Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Science translational medicine. 2018 Academic Article GET IT
Times cited: 257
End-of-life care for older AML patients relapsing after allogeneic stem cell transplant at a dedicated cancer center. Bone marrow transplantation. 2018 Academic Article GET IT
Times cited: 9
Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit). Cancer medicine. 2018 Academic Article GET IT
Times cited: 20
Early Fluid Overload Is Associated with an Increased Risk of Nonrelapse Mortality after Ex Vivo CD34-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 14
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Transplant infectious disease : an official journal of the Transplantation Society. 2018 Academic Article GET IT
Times cited: 11
Pretransplant comprehensive geriatric assessment in hematopoietic cell transplantation: a single center experience. Bone marrow transplantation. 2018 Article GET IT
Times cited: 20
Severe pembrolizumab-associated neutropenia after CD34⁺ selected allogeneic hematopoietic-cell transplantation for multiple myeloma. Bone marrow transplantation. 2018 Article GET IT
Times cited: 6
Reprint of: Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Information Resource GET IT
Times cited: 9
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34⁺ Selected and Unmodified Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 19
Revaccination after Autologous Hematopoietic Stem Cell Transplantation Is Safe and Effective in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 33
Burnout, Moral Distress, Work-Life Balance, and Career Satisfaction among Hematopoietic Cell Transplantation Professionals. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 101
Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors. Current opinion in oncology. 2017 Information Resource GET IT
Times cited: 12
Building a Safer and Faster CAR: Seatbelts, Airbags, and CRISPR. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Information Resource GET IT
Times cited: 40
Impact of Toxicity on Survival for Older Adult Patients after CD34⁺ Selected Allogeneic Hematopoietic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 13
Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 11
Real-world economic burden of hematopoietic cell transplantation among a large US commercially insured population with hematologic malignancies. Journal of medical economics. 2017 Academic Article GET IT
Times cited: 4
T Cell Depletion as an Alternative Approach for Patients 55 Years or Older Undergoing Allogeneic Stem Cell Transplantation as Curative Therapy for Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 8
The Impact of Toxicities on First-Year Outcomes after Ex Vivo CD34⁺-Selected Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 9
A Chemotherapy-Only Regimen of Busulfan, Melphalan, and Fludarabine, and Rabbit Antithymocyte Globulin Followed by Allogeneic T-Cell Depleted Hematopoietic Stem Cell Transplantations for the Treatment of Myeloid Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 6
Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 12
Real-World Economic Burden Associated with Transplantation-Related Complications. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 7
Co-Infections by Double-Stranded DNA Viruses after Ex Vivo T Cell-Depleted, CD34⁺ Selected Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 32
Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease. Blood. 2017 Academic Article GET IT
Times cited: 18
Allogeneic Hematopoietic Cell Transplantation for Adult T Cell Acute Lymphoblastic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 28
Protective Factors in the Intestinal Microbiome Against Clostridium difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation. The Journal of infectious diseases. 2017 Academic Article GET IT
Times cited: 68
Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 22
Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Academic Article GET IT
Times cited: 245
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 33
The effect of inter-unit HLA matching in double umbilical cord blood transplantation for acute leukemia. Haematologica. 2017 Academic Article GET IT
Times cited: 14
Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant. Leukemia & lymphoma. 2017 Academic Article GET IT
Times cited: 50
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma. Blood. 2017 Academic Article GET IT
Times cited: 192
Ex Vivo CD34⁺-Selected T Cell-Depleted Peripheral Blood Stem Cell Grafts for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Leukemia and Myelodysplastic Syndrome Is Associated with Low Incidence of Acute and Chronic Graft-versus-Host Disease and High Treatment Response. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 33
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer. Current hematologic malignancy reports. 2016 Information Resource GET IT
Times cited: 88
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34⁺ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 22
Timing Is Everything: Combining Post-Transplantation Adoptive Cell Therapy and Tumor Vaccines. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Article GET IT
Autoimmune hemolysis and immune thrombocytopenic purpura after cord blood transplantation may be life-threatening and warrants early therapy with rituximab. Bone marrow transplantation. 2016 Academic Article GET IT
Times cited: 13
Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Information Resource GET IT
Times cited: 81
Detection of human norovirus in intestinal biopsies from immunocompromised transplant patients. The Journal of general virology. 2016 Academic Article GET IT
Times cited: 76
Donor and recipient sex in allogeneic stem cell transplantation: what really matters. Haematologica. 2016 Academic Article GET IT
Times cited: 57
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Academic Article GET IT
Times cited: 22
Second Allogeneic Stem Cell Transplantation for Acute Leukemia Using a Chemotherapy-Only Cytoreduction with Clofarabine, Melphalan, and Thiotepa. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 10
Cytomegalovirus Infection after CD34(+)-Selected Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 28
Toxoplasma Encephalitis in Atypical Hosts at an Academic Cancer Center. Open forum infectious diseases. 2016 Academic Article GET IT
Times cited: 12
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation. British journal of haematology. 2016 Academic Article GET IT
Times cited: 108
Reprint of: Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Information Resource GET IT
Times cited: 2
The potential benefit of allogeneic over autologous transplantation in patients with very early relapsed and refractory follicular lymphoma with prior remission duration of ≤12 months. British journal of haematology. 2016 Academic Article GET IT
Times cited: 13
Phase II Study of Haploidentical Natural Killer Cell Infusion for Treatment of Relapsed or Persistent Myeloid Malignancies Following Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 114
Reduced-intensity transplantation for lymphomas using haploidentical related donors vs HLA-matched unrelated donors. Blood. 2015 Academic Article GET IT
Times cited: 235
Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2015 Academic Article GET IT
Times cited: 36
Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider. Current hematologic malignancy reports. 2015 Information Resource GET IT
Times cited: 42
The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy. Blood. 2015 Academic Article GET IT
Times cited: 254
Fast Cars and No Brakes: Autologous Stem Cell Transplantation as a Platform for Novel Immunotherapies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Information Resource GET IT
Times cited: 13
In Vivo T Cell Depletion with Myeloablative Regimens on Outcomes after Cord Blood Transplantation for Acute Lymphoblastic Leukemia in Children. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 18
Robust Vaccine Responses in Adult and Pediatric Cord Blood Transplantation Recipients Treated for Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 31
High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 37
CD34-Selected Hematopoietic Stem Cell Transplants Conditioned with Myeloablative Regimens and Antithymocyte Globulin for Advanced Myelodysplastic Syndrome: Limited Graft-versus-Host Disease without Increased Relapse. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 44
Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 16
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia. Blood. 2015 Academic Article GET IT
Times cited: 542
The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 45
Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 551
Intensified Mycophenolate Mofetil Dosing and Higher Mycophenolic Acid Trough Levels Reduce Severe Acute Graft-versus-Host Disease after Double-Unit Cord Blood Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 32
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study. The Lancet. Oncology. 2015 Academic Article GET IT
Times cited: 152
Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 32
Safety of voriconazole and sirolimus coadministration after allogeneic hematopoietic SCT. Bone marrow transplantation. 2015 Academic Article GET IT
Times cited: 15
Bone marrow or peripheral blood for reduced-intensity conditioning unrelated donor transplantation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 45
High day 28 ST2 levels predict for acute graft-versus-host disease and transplant-related mortality after cord blood transplantation. Blood. 2014 Academic Article GET IT
Times cited: 91
Incidence, nature and mortality of cytomegalovirus infection after double-unit cord blood transplant. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 24
Stem cell transplantation in Hodgkin lymphoma. Hematology/oncology clinics of North America. 2014 Information Resource GET IT
Times cited: 7
Favorable outcomes in elderly patients undergoing high-dose therapy and autologous stem cell transplantation for non-Hodgkin lymphoma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 50
Hematopoietic stem-cell transplantation for advanced systemic mastocytosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 144
Sirolimus, tacrolimus and low-dose methotrexate based graft-versus-host disease prophylaxis after non-ablative or reduced intensity conditioning in related and unrelated donor allogeneic hematopoietic cell transplant. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 18
The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood. 2014 Academic Article GET IT
Times cited: 671
Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 41
A prospective study of an alemtuzumab containing reduced-intensity allogeneic stem cell transplant program in patients with poor-risk and advanced lymphoid malignancies. Leukemia & lymphoma. 2014 Academic Article GET IT
Times cited: 8
Frequent human herpesvirus-6 viremia but low incidence of encephalitis in double-unit cord blood recipients transplanted without antithymocyte globulin. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 42
Challenges and potential solutions for recruitment and retention of hematopoietic cell transplantation physicians: the National Marrow Donor Program's System Capacity Initiative Physician Workforce Group report. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2014 Academic Article GET IT
Times cited: 10
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 113
Enhanced responses to tumor immunization following total body irradiation are time-dependent. PloS one. 2013 Academic Article GET IT
Times cited: 12
A phase II study of a nonmyeloablative allogeneic stem cell transplant with peritransplant rituximab in patients with B cell lymphoid malignancies: favorably durable event-free survival in chemosensitive patients. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 35
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications. Journal of cellular and molecular medicine. 2013 Information Resource GET IT
Times cited: 52
Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors. Haematologica. 2013 Academic Article GET IT
Times cited: 66
Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nature medicine. 2013 Academic Article GET IT
Times cited: 159
A novel reduced-intensity conditioning regimen induces a high incidence of sustained donor-derived neutrophil and platelet engraftment after double-unit cord blood transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 56
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 58
Who is the better donor for older hematopoietic transplant recipients: an older-aged sibling or a young, matched unrelated volunteer?. Blood. 2013 Academic Article GET IT
Times cited: 110
Phase II study of bendamustine in relapsed and refractory Hodgkin lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 172
Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. Blood. 2012 Academic Article GET IT
Times cited: 141
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2012 Academic Article GET IT
Times cited: 37
Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants. Bone marrow transplantation. 2012 Academic Article GET IT
Times cited: 43
Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012 Academic Article GET IT
Times cited: 746
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 35
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failure. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 21
Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma. Blood. 2011 Academic Article GET IT
Times cited: 250
Serious infection risk and immune recovery after double-unit cord blood transplantation without antithymocyte globulin. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 90
Reduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 66
T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2011 Academic Article GET IT
Times cited: 67
Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation. PloS one. 2010 Academic Article GET IT
Times cited: 220
Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT. Bone marrow transplantation. 2010 Academic Article GET IT
Times cited: 21
Cytokine-FC fusion genes as molecular adjuvants for DNA vaccines. Methods in molecular biology (Clifton, N.J.). 2010 Academic Article GET IT
Times cited: 3
Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma. British journal of haematology. 2009 Academic Article GET IT
Times cited: 134
Self-antigen-specific CD8+ T cell precursor frequency determines the quality of the antitumor immune response. The Journal of experimental medicine. 2009 Academic Article GET IT
Times cited: 91
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation. Blood. 2008 Academic Article GET IT
Times cited: 24
Phase I/II study of GM-CSF DNA as an adjuvant for a multipeptide cancer vaccine in patients with advanced melanoma. Molecular therapy : the journal of the American Society of Gene Therapy. 2008 Academic Article GET IT
Times cited: 80
Response to pneumococcal (PNCRM7) and haemophilus influenzae conjugate vaccines (HIB) in pediatric and adult recipients of an allogeneic hematopoietic cell transplantation (alloHCT). Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 60
Rituximab-responsive Guillain-Barré syndrome following allogeneic hematopoietic SCT. Bone marrow transplantation. 2008 Letter GET IT
Times cited: 30
Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2008 Academic Article GET IT
Times cited: 59
Clinical strategies to enhance T cell reconstitution. Seminars in immunology. 2007 Information Resource GET IT
Times cited: 60
Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 38
Safety and immunogenicity of tyrosinase DNA vaccines in patients with melanoma. Molecular therapy : the journal of the American Society of Gene Therapy. 2007 Academic Article GET IT
T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood. 2007 Academic Article GET IT
Times cited: 103
Posterior reversible encephalopathy syndrome due to sirolimus. Bone marrow transplantation. 2007 Article GET IT
Times cited: 25
Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2007 Academic Article GET IT
Times cited: 24
Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains. Clinical cancer research : an official journal of the American Association for Cancer Research. 2006 Academic Article GET IT
Times cited: 41
DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation. Journal of immunology (Baltimore, Md. : 1950). 2006 Academic Article GET IT
Times cited: 16
Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature medicine. 2006 Academic Article GET IT
Times cited: 145
Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants. Blood. 2006 Academic Article GET IT
Times cited: 61
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunity. Cancer research. 2006 Academic Article GET IT
Times cited: 183
Comparison of two cancer vaccines targeting tyrosinase: plasmid DNA and recombinant alphavirus replicon particles. Clinical cancer research : an official journal of the American Association for Cancer Research. 2005 Academic Article GET IT
Times cited: 47
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center. Vaccine. 2005 Academic Article GET IT
Times cited: 197
IL-15: targeting CD8+ T cells for immunotherapy. Cytotherapy. 2005 Information Resource GET IT
Immunizing against partially defined antigen mixtures, gangliosides, or peptides to induce antibody, T cell, and clinical responses. Cancer chemotherapy and biological response modifiers. 2005 Information Resource GET IT
Times cited: 5
CD4 help and tumor immunity: beyond the activation of cytotoxic T lymphocytes. Annals of surgical oncology. 2004 Editorial Article GET IT
Times cited: 5
Granulocyte-macrophage colony stimulating factor: an adjuvant for cancer vaccines. Hematology (Amsterdam, Netherlands). 2004 Information Resource GET IT
CTLA-4 blockade in combination with xenogeneic DNA vaccines enhances T-cell responses, tumor immunity and autoimmunity to self antigens in animal and cellular model systems. Vaccine. 2004 Academic Article GET IT
Times cited: 107
Redundant and alternative roles for activating Fc receptors and complement in an antibody-dependent model of autoimmune vitiligo. Immunity. 2002 Academic Article GET IT
Times cited: 57
GM-CSF DNA induces specific patterns of cytokines and chemokines in the skin: implications for DNA vaccines. Cytokines, cellular & molecular therapy. 2002 Academic Article GET IT
Times cited: 24
Melanoma vaccines. Cancer investigation. 2002 Information Resource GET IT
Times cited: 16
Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease. Blood. 2001 Academic Article GET IT
Times cited: 171
Alternative roles for interferon-gamma in the immune response to DNA vaccines encoding related melanosomal antigens. Cancer immunity. 2001 Academic Article GET IT
Times cited: 11
Serum enhances the ex vivo generation of HIV-specific cytotoxic T cells. Biotechnology and bioengineering. 1996 Academic Article GET IT
Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage. AIDS research and human retroviruses. 1996 Academic Article GET IT
Times cited: 12
A vaccinia-gp160-based vaccine but not a gp160 protein vaccine elicits anti-gp160 cytotoxic T lymphocytes in some HIV-1 seronegative vaccinees. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1995 Academic Article GET IT
Times cited: 30
Radioisotopic assay of aspartate and alanine aminotransferase. Clinical biochemistry. 1992 Academic Article GET IT
Times cited: 11
Hexose metabolism in pancreatic islets: the glucose-6-phosphatase riddle. Molecular and cellular biochemistry. 1991 Academic Article GET IT
Times cited: 16

more ...

less ...

Background

education and training

M.D., Free University of Bruxelles Faculty of Medicine (Belgium) 91

Contact

full name

Miguel-Angel Perales

VIVO Weill Cornell Medical College

Miguel-Angel Perales Professor of Medicine

Publications

selected publications

Background

education and training

Contact

full name

Phone

Publications

selected publications

Background

education and training

Contact

full name